OTC Pharmaceuticals and Self-medication in Seven Emerging Markets |
A
growing elderly population, rising obesity and a huge number of smokers are key
contributors to a surging Over-The-Counter (OTC) drugs market in Russia, states
a new published report.
The
firm’s latest publication predicts the country’s OTC market to climb in value
from last year’s total of US$7.1 billion to US$16 billion by just 2018, at an
impressive Compound Annual Growth Rate of 12.4% – the highest of any of the
seven emerging markets investigated.
According
to report, the lifestyle OTC medications sector is a significant contributor to
the industry, accounting for 19% of the total last year, and is expected become
the number one OTC market contributor in the future as more Russian’s seek to
address unhealthy habits.
The
Eastern European nation is home to the largest percentage of smokers in the
world and has a growing problem with obesity, but a strong lifestyle OTC
industry indicates a healthy cultural desire to combat these issues.
The
cough, cold and allergy category also holds a large market share at 18%. Since
the fall of the Soviet Union, tuberculosis has been on the rise, and while this
is a serious condition that requires medical attention and prescription drugs,
it is likely that OTC products will be used alongside professional treatments
to help ease disease symptoms.
Despite
having a far greater population, China’s OTC market value is expected to be
only marginally greater than Russia’s in 2018, at US$16.6 billion. Of the seven
emerging markets identified in report, Brazil is predicted to have the third
biggest OTC market value at US$8.3 billion, while India is placed fourth at
US$5.2 billion.
This report provides insights into the
up-and-coming trends of the Over the Counter (OTC) pharmaceutical market by
analyzing the trends in population health, healthcare and self-care in seven
emerging markets: China, India, Russia, Brazil, Mexico, Indonesia and Turkey.
To purchase and know more about this market research report please visit: OTC Pharmaceuticals and Self-medication in Seven Emerging Markets
No comments:
Post a Comment
Note: only a member of this blog may post a comment.